After a 16% crash, the market is discounting Arm and more
Apollo, Blackstone, and BlackRock won’t fund on a 25% backstop
Tariff refunds, advertising growth, and e-commerce strength rewrote Q2.
The $32 billion in commitments disclosed Tuesday activate only if recipients can first secure financing, raising questions...
Record fee-related earnings, 27% FRE growth, and a $1 trillion AUM target by 2030. The rate environment...
With the stock about 59% off its peak and a $664 billion backlog, Oracle has become the...
October retail sales land this morning into the most yield-hostile backdrop stocks have faced all year.
October retail sales grew only 0.4% despite the National Day holiday. Investors now have to decide whether...
FDA rejection of Summit’s ivonescimab tests the case for in-licensed Chinese cancer drugs.
NGS ARR up 63%, CyberArk closed, stock 25% off its high. Q1 FY2027 drops Wednesday.
